Virtual Reality Competency-based Simulation Training Improves Early Patient Outcomes in Cataract Surgery

November 9, 2026 updated by: Amalie Carlsson, Copenhagen Academy for Medical Education and Simulation

The Effect of Cataract Surgical Simulation Training on Patient Outcomes

This study investigated the effect of virtual reality simulation training (VRST) on early patient outcomes following cataract surgery performed by novice surgeons. Nine novice cataract surgeons were divided into two groups based on previous VRST experience. Group allocation was determined by regional differences in simulator availability rather than randomization. Each surgeon performed three cataract surgeries before and three after completing competency-based VRST. The primary outcomes were postoperative corneal swelling and best-corrected visual acuity (BCVA), assessed preoperatively and on the first postoperative day. Phacoemulsification energy use was evaluated as a secondary outcome.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study investigated the effect of virtual reality simulation training (VRST) on early patient outcomes following cataract surgery performed by novice surgeons.

Nine novice cataract surgeons, each having performed fewer than ten independent cataract surgeries, were included from three regions in Denmark. Surgeons were divided into two groups based on previous VRST experience: five VRST-naïve surgeons and four VRST-experienced surgeons. Differences in previous VRST experience reflected regional variation in simulator availability, and no randomization was performed.

Each surgeon performed three cataract surgeries before and three after completing VRST on the EyeSi Surgical Simulator. Both groups received the same training intervention. All sur-geons also received standard surgical training and supervision according to routine clinical practice at their respective institutions. These training and supervision practices were not modified as part of the study.

Patients undergoing routine cataract surgery were included in the study. All patients were scheduled to undergo surgery performed by novice surgeons as part of routine clinical prac-tice, independently of study participation. Patients were not allocated to surgeons based on the study protocol, and the study did not alter their planned surgical treatment. The study-specific intervention consisted exclusively of simulation-based training provided to the sur-geons.

Patient outcomes were assessed preoperatively and on the first postoperative day. The pri-mary outcomes were postoperative corneal swelling, measured as the change in central cor-neal thickness from preoperative assessment to the first postoperative day, and best-corrected visual acuity (BCVA), assessed preoperatively and on the first postoperative day. Cumulative dissipated energy (CDE) during phacoemulsification was evaluated as a second-ary outcome.

The study aimed to investigate whether previous VRST experience was associated with dif-ferences in early patient outcomes and whether these differences changed following VRST, particularly among surgeons without previous VRST experience.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Copenhagen
      • Glostrup Municipality, Copenhagen, Denmark, 2700
        • Department of ophthalmology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Age >18 years.

Capacity to provide informed consent.

Scheduled to undergo cataract surgery at the Department of Ophthalmology, Rigshospitalet-Glostrup, Aarhus University Hospital, or Aalborg University Hospital.

Exclusion Criteria:

History of epiretinal membrane.

History of retinal vein occlusion.

History of retinal detachment.

History of uveitis.

Glaucoma.

Diabetes mellitus.

Exudative age-related macular degeneration (AMD) or AMD with geographical atrophy.

Inability to fully cooperate.

Shallow anterior chamber (corneal epithelium to lens <2.3 mm).

Small pupils requiring anticipated intraoperative use of a Malyugin ring.

Fuchs' endothelial dystrophy, defined as >20 central guttatae and endothelial cell density <2,000 cells/mm².

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VRST intervention

All partiicpants regardless of previous virtual reality simulation training experience, received an virtual reality simulation training intervention after the surgeons' first 3 independent cataract operations

competency-based virtual reality simulation. The surgeons were required to train on the simulator until they were able to pass a proficiency test on the simulator

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative corneal swelling
Time Frame: 1 day

central corneal thickness (CCT) measured preoperatively and on the first postoperative day. Corneal swelling is calculated by substracting postoperative CCT from preoperative CCT

1 day
Best corrected visual acuity (BCVA)
Time Frame: 1 day

Measured preoperatively and on the first postoperative day. Part of standard evaluation and checkup on cataract surgical patients. Outcome is the calculated difference between preoperative and postoperative BCVA

1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cumulative Dissipated Phacoemulsification Energy
Time Frame: N/A measured on the day of the surgery

The amount of phacoemulsification energy used during the cataract surgical procedure

N/A measured on the day of the surgery
Intraoperative ocular pressure (IOP)
Time Frame: 1 day

IOP measured as part of the standard evaluation of the cataract patient. Measured preoperatively and on the first postoperative day

1 day
CATQUEST 7SF
Time Frame: 3 months

Questionnare of patient satisfaction with his/her vission. The patient filled out the questionnare preoperatively and 3 month postoperatively

3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Ann Sofia S Thomsen, MD, PhD, Department of Ophthalmology, Rigshospitalet-Glostrup, Copenhagen, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Actual)

November 7, 2025

Study Completion (Actual)

December 1, 2025

Study Registration Dates

First Submitted

November 9, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 13, 2026

Study Record Updates

Last Update Posted (Actual)

November 13, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H-20022813

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.